好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Michigan Neuropathy Screening Instrument: A tool for diabetic peripheral neuropathy diagnosis in a rural area in Ecuador.
General Neurology
P13 - Poster Session 13 (8:00 AM-9:00 AM)
12-001
This study aims to evaluate the usefulness of the Michigan Neuropathy Screening Instrument in diabetic patients in a primary care center in a rural area of Ecuador.
Diabetic peripheral neuropathy (DPN) is one of the most common microvascular complications of type 2 diabetes mellitus (T2DM).Its devastating consequences such as chronic pain, foot ulcers, and limb amputation require early detection and management to reduce complications associated with the disease. The MNSI is a screening tool for DPN that includes two assessments: Part A, a questionnaire done by the patient and Part B, the inspection and assessment of vibratory sensation and ankle reflexes provided by the physician.
This is an observational and cross-sectional study. We included all diabetic patients that attended to our primary care center that is located in a rural area of Jipijapa, Ecuador from January to October 2022 and that had updated blood work. Data was analyzed using SPSS v. 25.

Out of the 30 patients that were included in the study, 53.3% were females and 46.7% were males. The mean age of the population was 65 years. 26.7% were illiterate patients, 63.3% were low-literacy and 10% were middle-educated patients. A total of 22 patients tested positive for DPN in part B MSNI, but only 6 were positive for part A. This might be attributed to the low-literacy in our study population. The Michigan part A median score was 6 SD± 2 and the part B median score was 4.1 SD± 1.9. Patients who had DPN according to MNSI part B had a median glucose of 217 mg/dl. MNSI part B showed a positive relationship with creatinine levels (p= 0.021).

MNSI can be used as a screening tool for DNP in limited-resourced settings where only clinical assessment is possible.
Authors/Disclosures
Daniella A. Bustamante, MD (Instituto Ecuatoriano de Seguridad Social)
PRESENTER
Dr. Bustamante has nothing to disclose.
No disclosure on file
No disclosure on file